<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Sepsis Caused by Extended-Spectrum Beta-Lactamase (ESBL)-Positive K. pneumoniae and E. coli: Comparison of Severity of Sepsis, Delay of Anti-Infective Therapy and ESBL Genotype</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-07-21">July 21, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Christian</forename><surname>Sakellariou</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Hygiene and Environmental Medicine</orgName>
								<orgName type="institution" key="instit1">National Reference Center for the Surveillance of Nosocomial Infections</orgName>
								<orgName type="institution" key="instit2">Charité Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>Hindenburgdamm 27</addrLine>
									<postCode>12203</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephan</forename><surname>Gürntke</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Hygiene and Environmental Medicine</orgName>
								<orgName type="institution" key="instit1">National Reference Center for the Surveillance of Nosocomial Infections</orgName>
								<orgName type="institution" key="instit2">Charité Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>Hindenburgdamm 27</addrLine>
									<postCode>12203</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ivo</forename><surname>Steinmetz</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Friedrich Loffler Institute of Medical Microbiology</orgName>
								<orgName type="institution">Universitaetsmedizin Greifswald</orgName>
								<address>
									<addrLine>Martin-Luther-Str.6</addrLine>
									<postCode>17475</postCode>
									<settlement>Greifswald, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><surname>Kohler</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Friedrich Loffler Institute of Medical Microbiology</orgName>
								<orgName type="institution">Universitaetsmedizin Greifswald</orgName>
								<address>
									<addrLine>Martin-Luther-Str.6</addrLine>
									<postCode>17475</postCode>
									<settlement>Greifswald, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yvonne</forename><surname>Pfeifer</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">Robert Koch Institute</orgName>
								<orgName type="institution" key="instit2">Nosocomial Pathogens and Antibiotic Resistance</orgName>
								<address>
									<postCode>FG13, 38855</postCode>
									<settlement>Wernigerode, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Petra</forename><surname>Gastmeier</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Hygiene and Environmental Medicine</orgName>
								<orgName type="institution" key="instit1">National Reference Center for the Surveillance of Nosocomial Infections</orgName>
								<orgName type="institution" key="instit2">Charité Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>Hindenburgdamm 27</addrLine>
									<postCode>12203</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Frank</forename><surname>Schwab</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Hygiene and Environmental Medicine</orgName>
								<orgName type="institution" key="instit1">National Reference Center for the Surveillance of Nosocomial Infections</orgName>
								<orgName type="institution" key="instit2">Charité Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>Hindenburgdamm 27</addrLine>
									<postCode>12203</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Axel</forename><surname>Kola</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Hygiene and Environmental Medicine</orgName>
								<orgName type="institution" key="instit1">National Reference Center for the Surveillance of Nosocomial Infections</orgName>
								<orgName type="institution" key="instit2">Charité Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>Hindenburgdamm 27</addrLine>
									<postCode>12203</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maria</forename><surname>Deja</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Anesthesiology and Intensive Care</orgName>
								<orgName type="institution">Charité Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin, Hindenburgdamm 30</addrLine>
									<postCode>12203</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Rasmus</forename><surname>Leistner</surname></persName>
							<email>rasmus.leistner@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Institute of Hygiene and Environmental Medicine</orgName>
								<orgName type="institution" key="instit1">National Reference Center for the Surveillance of Nosocomial Infections</orgName>
								<orgName type="institution" key="instit2">Charité Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>Hindenburgdamm 27</addrLine>
									<postCode>12203</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="institution">The University of Hong Kong</orgName>
								<address>
									<country key="CN">CHINA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Sepsis Caused by Extended-Spectrum Beta-Lactamase (ESBL)-Positive K. pneumoniae and E. coli: Comparison of Severity of Sepsis, Delay of Anti-Infective Therapy and ESBL Genotype</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-07-21">July 21, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">804CD023CF1C1431C4DFA23C3505E8DC</idno>
					<idno type="DOI">10.1371/journal.pone.0158039</idno>
					<note type="submission">Received: January 20, 2016 Accepted: June 9, 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:26+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) are associated with increased mortality.</s><s>Outcome differences due to various species of ESBL-E or ESBL genotypes are not well investigated.</s><s>We conducted a cohort study to assess risk factors for mortality in cases of ESBL-E bacteremia (K.</s><s>pneumoniae or E. coli) and the risk factors for sepsis with organ failure.</s><s>All consecutive patients of our institution from 2008 to 2011 with bacteremia due to ESBL-E were included.</s><s>Basic epidemiological data, underlying comorbidities, origin of bacteremia, severity of sepsis and delay of appropriate anti-infective treatment were collected.</s><s>Isolates were PCR-screened for the presence of ESBL genes and plasmid-mediated AmpC β-lactamases.</s><s>Cox proportional hazard regression on mortality and multivariable logistic regression on risk factors for sepsis with organ failure was conducted.</s><s>219 cases were included in the analysis: 73.1% due to E. coli, 26.9% due to K. pneumoniae.</s><s>There was no significant difference in hospital mortality (ESBL-E.</s><s>coli, 23.8% vs. ESBL-K.</s><s>pneumoniae 27.1%, p = 0.724).</s><s>However, the risk of sepsis with organ failure was associated in cases of K. pneumoniae bacteremia (OR 4.5, p&lt;0.001) and patients with liver disease (OR 3.4, p = 0.004) or renal disease (OR 6.8, p&lt;0.001).</s><s>We found significant differences in clinical presentation of ESBL-E bacteremia due to K. pneumoniae compared to E. coli.</s><s>As K. pneumoniae cases showed a more serious clinical presentation as E. coli cases and were associated with different risk factors, treatment and prevention strategies should be adjusted accordingly.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) are associated with impaired outcome compared to infections with susceptible pathogens <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref>.</s><s>Former studies on ESBL-E bacteremia proved that a delay of adequate antimicrobial chemotherapy can be an important factor on mortality <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b3">4]</ref>.</s><s>This effect seems to be the most evident in cases of septic shock or organ failure <ref type="bibr" target="#b5">[5]</ref>.</s><s>This is even more important since there is evidence that infections due to K. pneumoniae are associated with a worse course compared to other Enterobacteriaceae <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b6">6,</ref><ref type="bibr" target="#b7">7]</ref>.</s><s>However, studies concerning ESBL-E infections often do not differentiate between the infecting species.</s><s>There are only few studies comparing outcome parameter of different Enterobacteriaceae <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b6">6,</ref><ref type="bibr" target="#b8">[8]</ref><ref type="bibr" target="#b9">[9]</ref><ref type="bibr" target="#b10">[10]</ref>.</s><s>To analyze the effect of the different ESBL-E species on mortality and on the clinical presentation, we conducted a cohort study comparing cases of ESBL-positive K. pneumoniaeand E. coli bacteremia including data on the timing of their antimicrobial treatment.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study design</head><p><s>We conducted a retrospective cohort study on patients with bacteremia due to ESBL-E.</s><s>The setting of this study was the Charité University Hospital in Berlin, Germany, a tertiary care university hospital with over 120,000 admissions per year.</s><s>Previously, our ethics committee approved the study without informed consent.</s><s>The patient data based on secondary clinical information.</s><s>The biological material was obtained clinically and analyzed by a separate institution after anonymization in our institution (reference number EA4/031/11).</s><s>Parts of the study have been published in different analyses including differing data sets <ref type="bibr" target="#b10">[10,</ref><ref type="bibr" target="#b11">11]</ref>.</s></p><p><s>All inpatients with ESBL-E bacteremia (E. coli or K. pneumoniae) diagnosed between January 1 st , 2008 and December 31 st 2011 were included.</s><s>The bacteremia was classified as hospital onset if a positive blood culture was collected after the third hospital day.</s><s>In case of more than one cultured organism in the first positive blood culture, the episode was defined as polymicrobial bacteremia.</s><s>If the patient showed multiple subsequent positive blood cultures, the first positive blood culture lead to the allocation to one of the two pathogens and this episode was included in the analysis.</s><s>Underlying comorbidities were assessed according to the method by Charlson et al. <ref type="bibr" target="#b12">[12]</ref>.</s><s>The comorbidities were collected using the patients' ICD-10 codes and grouped for the calculation of the Charlson comorbidity index (CCI) according to the method by Thygesen et al. <ref type="bibr" target="#b13">[13]</ref>.</s></p><p><s>Further clinical parameters were collected by analysis of the patients' files.</s><s>To assess the origin of ESBL bacteremia we collected data on earlier infections during the analyzed hospital stay.</s><s>These infections were due to same ESBL-positive organisms as the corresponding bacteremia episode and at maximum 14 days prior to the bacteremia onset.</s><s>The infections were assessed according to the CDC definitions <ref type="bibr" target="#b14">[14]</ref>.</s><s>Primary bacteremia was defined as central venous catheter (CVC) &lt;48h prior to the bacteremia onset without presence of another ESBL-E infection.</s><s>Mortality was defined as in-hospital mortality and ESBL colonization was assessed as colonization with ESBL-E prior to the bacteremia episode at any site.</s><s>Sepsis, severe sepsis, and septic shock were defined according to the definitions of the consensus conference of the American College of Chest Physicians and the Society of Critical Care Medicine which also find application in Germany <ref type="bibr" target="#b15">[15,</ref><ref type="bibr" target="#b16">16]</ref>.</s><s>Delay of anti-infective treatment (DAT) was defined as initiation of effective treatment 1 day after onset of bacteremia.</s><s>Effective treatment was defined as an antimicrobial agent the ESBL-positive organism was tested susceptible against.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Microbiological methods</head><p><s>Species identification and antimicrobial susceptibility testing was performed using the Vitek 2 automated system with interpretation and antibiogram reporting according to the CLSI standard <ref type="bibr" target="#b18">[17]</ref>.</s><s>Confirmation of ESBL production was performed by a minimum inhibitory concentration dilution test on a multiwell microtiter plate.</s><s>Three cephalosporins (cefotaxime, ceftazidime, cefpodoxime) were tested alone and in combination with ESBL inhibitor clavulanic acid.</s><s>All verification swabs were inoculated onto chrome ID ESBL agar (BioMerieux).</s><s>ESBL-positive isolates were affirmed by Double Disc Synergie Testing using 3rd generation cephalosporins with/without clavulanic acid (Mast).</s><s>Species confirmation was done by API20E (BioMerieux).</s><s>The isolates were screened for the presence of different ESBL genes (blaTEMtype, blaSHV-type, blaCTX-M-1/2/9 group) by polymerase chain reaction (PCR) and subsequent sequencing <ref type="bibr" target="#b19">[18]</ref>.</s><s>If none of these ESBL genes could be identified, additional PCR tests for the presence of plasmid-mediated AmpC β-lactamases <ref type="bibr" target="#b20">[19]</ref> and further ESBL genes (blaCTX-M-8-type, blaCTX-M-26-type) were performed <ref type="bibr" target="#b21">[20]</ref>.</s><s>Furthermore, basic bacterial typing of all ESBL-positive E. coli isolates was performed by a PCR-based method for determination of the four major E. coli phylogenetic groups <ref type="bibr" target="#b22">[21]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical methods</head><p><s>Parameters in the univariate analysis were tested using the Wilcoxon rank sum test for continuous variables and the Fisher's exact test for categorical variables.</s><s>For the analysis of factors associated to severity of illness, the categories were transformed to a binary category as bacteremia (bacteremia and sepsis) vs. sepsis with organ failure (severe sepsis and septic shock).</s><s>Clinical parameter of E. coliand K. pneumoniaecases were compared using univariate analysis.</s><s>Multivariable binary logistic analysis using a stepwise forward regression was computed for the analysis of clinical risk factors for sepsis with organ failure.</s><s>We compared the clinical parameter of the deceased patients and the alive discharged patients using univariate analysis.</s><s>We calculated adjusted hazard ratios for in-hospital death using Cox-proportional hazard regression using a stepwise forward approach.</s><s>In both multivariable analyses, parameters with p-values &lt;0.20 in the univariate analyses were considered in the analysis.</s><s>Variables with p-values &lt;0.05 were included and variables with p0.05 were excluded.</s><s>All tests of were two tailed with a pvalue &lt;0.05 considered to be significant.</s><s>Data was analyzed using IBM SPSS Statistics Version 22.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>We identified altogether 243 consecutive cases of bacteremia, 177 cases due to ESBL-positive E. coli (73.1%) and 66 cases due to K. pneumoniae (27.2%) together.</s><s>No case showed both analyzed pathogens in the same blood culture.</s><s>From twenty-three cases (9.9%), sufficient data was not available and therefore excluded.</s><s>The remaining 219 cases were analyzed (n = 160, 73.1% due to E. coli and n = 59, 26.9% due to K. pneumoniae).</s><s>We found an increasing risk for mortality in relation to the applied definitions for severity of sepsis (Fig <ref type="figure" target="#fig_0">1</ref>).</s><s>The characteristics of the analyzed cohort stratified by infecting organism are given in S1 Table <ref type="table">.</ref></s><s>Patients suffering from ESBL-positive K. pneumoniae bacteremia (ESBL-KP-Bac) were younger than the compared patients with ESBL-positive E. coli bacteremia (ESBL-EC-Bac).</s><s>They more often had a secondary bacteremia due to a surgical site infection and more often an unknown source of infection.</s><s>ESBL-KP-Bac was more often associated with sepsis with organ failure.</s><s>Patients with sepsis with organ failure showed significantly reduced DAT compared to patients presenting with bacteremia only (Median 0 days, IQR 0;2 days vs. Median 2 days, IQR 0;3 days, p = 0.003).</s><s>Patients with ESBL-KP-Bac showed an increased mortality compared to ESBL-EC-Bac (27.1% vs. 23.8%)</s><s>but not statistical significant.</s><s>ESBL-EC-Bac however, was more common among patients with previous urinary tract infection.</s><s>The mostly used antimicrobial agents after infection onset were carbapenems: 71.2% (n = 156), quinolones 12.3% (n = 27), tigecyclin 5.0% (n = 11), piperacillin-tazobactam 2.3% (n = 5) and gentamicin 2.3% (n = 5).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Microbiology parameter</head><p><s>In the clinically reported antibiogram, 98.6% (n = 216) isolates were resistant to piperacillin/ tazobactam, 98.2% (n = 215) to ceftazidime, 69.4% (n = 152) to ciprofloxacin and 43.4% (n = 95) to gentamicin.</s><s>None of the included isolates was reported resistant to the carbapenems imipenem or meropenem.</s><s>Of the 219 isolates, 88.5% (n = 194) were available for further ESBL genotype analysis; the remaining 25 were not retrievable.</s><s>The distribution of the ESBL genotypes is shown in Tables <ref type="table" target="#tab_3">1 and 2</ref> with overall CTX-M-15, CTX-M-1, CTX-M-14 and SHV-5 as most common types.</s><s>One-hundred and seven isolates (55.2%) carried two or more TEM-or SHV-type beta-lactamases.</s><s>Seven isolates (3.6%) did not carry an ESBL gene.</s><s>Five showed either TEM-181, TEM-1 or SHV-1 overproduction, one was CMY-positive and one did not show any beta-lactamase at all.</s><s>The distribution pattern of the phylogenetic groups within the analyzed 140 E. coli isolates was B2 (33.6%, n = 47), A (28.6%, n = 40), D (26.4%, n = 37) and B1 (11.4%, n = 16).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Factors associated with sepsis with organ failure</head><p><s>Table <ref type="table">3</ref> shows the results of the multivariable analysis on risk factors for sepsis with organ failure.</s><s>The K. pneumoniae cases were associated with 4.5 times higher odds for an organ failure at presentation.</s><s>Furthermore, sepsis with organ failure was associated with liver disease (OR 3.3) and moderate to severe renal disease (OR 6.835).</s><s>Factors associated with in-hospital mortality (Cox-proportional hazard analysis)</s></p><p><s>The results of the univariate analysis on in-hospital mortality are displayed in Table <ref type="table" target="#tab_2">2</ref>.</s><s>In order to assess the effect of the infecting organism (E. coli vs. K. pneumoniae) on mortality this parameter was also considered in the Cox-proportional hazard regression.</s><s>The deceased had significantly higher CCIs.</s><s>These patients also had significantly more often a hospital onset bacteremia, sepsis with organ failure, prior episodes of lower respiratory tract infection, intraabdominal infection or primary bacteremia, underlying heart disease, liver-or renal disease.</s><s>The survivors had more commonly a urinary tract infection prior to their bacteremia.</s><s>The results of the Cox-proportional hazard regression (Table <ref type="table" target="#tab_4">4</ref>) showed that sepsis with organ failure was associated with a 4.5-fold higher hazard for mortality, renal disease and liver disease with 2.7-fold and 1.8-fold elevated hazard.</s><s>The only protective factor was urinary tract infection that was associated with a hazard reduction for mortality of about 61% (HR 0.39).</s><s>There was no statistically significant difference in the mortality risk between both species.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In this study ESBL-KP-Bac bacteremia was associated with different origin, with sepsis with organ failure and younger age compared to ESBL-EC-Bac cases (S1 Table <ref type="table">)</ref>.</s><s>Our results underline the findings of previous studies showing that K. pneumoniae infections are associated with more serious illness than E. coli infections <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b6">6,</ref><ref type="bibr" target="#b7">7,</ref><ref type="bibr" target="#b23">22]</ref>.</s><s>Even though K. pneumoniae bacteremia was not associated with delayed adequate anti-infective treatment it was associated with slightly increased mortality, but it did not reach the significance level.</s><s>The small sub-cohort of ESBL-KP-Bac might explain this.</s><s>Several studies show that a delay of adequate antimicrobial chemotherapy is a risk factor for in-hospital death <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b3">4]</ref>.</s><s>In our cohort, the association of sepsis with organ failure and reduced DAT demonstrate most likely the realization of the German sepsis guidelines <ref type="bibr" target="#b24">[23]</ref>.</s><s>Patients who present with severe sepsis or septic shock are recommended to be immediately initiated with an early initial broad-spectrum treatment including reserve antibiotics e.g.</s><s>carbapenems.</s><s>In our study, the presentation of severe sepsis happened before the initiation of the antimicrobial therapy.</s><s>Hence, the observed association between disease severity and reduced DAT represents the response to the severity of the disease and not the cause of the disease.</s><s>This refers to the observation that in sepsis with organ failure, an early effective antimicrobial therapy is associated with significantly reduced mortality risk <ref type="bibr" target="#b25">[24]</ref>.</s><s>Even though most cases of sepsis with organ failure received appropriate antimicrobial therapy within the first day, more than 25% showed a DAT of more than 1 day.</s><s>This observation might at least partly explain the remaining high mortality (51.9%) in patients with severe sepsis and septic shock.</s><s>ESBL-KP-Bac cases were associated with sepsis with organ failure.</s><s>However, they did not show significant differences in comorbidities compared to ESBL-EC-Bac cases (S1 Table <ref type="table">)</ref>.</s><s>This might be explained by a potentially higher virulence of K. pneumoniae compared to E. coli.</s><s>An earlier study on length of hospital stay included parts of the data at hand.</s><s>Altogether 1.851 cases of bacteremia with (ESBL-positive and-negative) Enterobacteriaceae were analyzed then <ref type="bibr" target="#b10">[10]</ref>.</s><s>In that study, K. pneumoniae cases were associated with significantly prolonged hospital stay compared to E. coli cases.</s><s>This most likely indicates a more problematic course of infection in K. pneumoniae cases.</s><s>However, in that former study no data on antimicrobial therapy was analyzed <ref type="bibr" target="#b10">[10]</ref>.</s><s>Our present results support the previous findings after adjustment for timely and adequate antimicrobial therapy.</s><s>The primary source of bacteremia differed significantly between both pathogens.</s><s>While E. coli bacteremia was mostly found secondary to a urinary tract infection, K. pneumoniae cases were associated with surgical site infection (SSI), lower respiratory tract infection (LRTI) and unknown origin.</s><s>Besides undetected colonization, the latter could be explained by health-care associated transmission.</s><s>However, all sites of origin (SSI, LRTI and transmission) are likely since K. pneumoniae is often identified as outbreak pathogen <ref type="bibr" target="#b26">[25,</ref><ref type="bibr" target="#b27">26]</ref> and shows higher transmission potential than E. coli <ref type="bibr" target="#b28">[27]</ref>.</s></p><p><s>Urinary tract infection (UTI) as possible source of bacteremia was found less often associated with the development of a fatal bacteremia.</s><s>This goes along with former studies on ESBL-E bacteremia <ref type="bibr" target="#b7">[7,</ref><ref type="bibr" target="#b29">28]</ref>.</s><s>ESBL-E are common pathogens of urinary tract infections.</s><s>A prior microbiologically diagnosed ESBL-E UTI might have supported an early initiation of antiinfective treatment at presentation of a secondary bacteremia.</s></p><p><s>Even though there are significant differences in the ESBL genotype distribution of both pathogens, none of these genotypes was associated with increased mortality.</s><s>However, our data confirms that the most common genotypes among clinical ESBL-positive E. coli isolates in the United States and in Europe are currently CTX-M-15 and CTX-M-14 <ref type="bibr" target="#b30">[29,</ref><ref type="bibr" target="#b32">30]</ref>.</s><s>In our K. pneumoniae isolates the most common ESBL genotypes were CTX-M-15 and SHV-5 which is also commonly observed in Europe <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b33">31]</ref>.</s></p><p><s>In our study, most of the isolates were reported resistant against piperacillin-tazobactam (pip-taz) due to their ESBL positivity.</s><s>In 2011, CLSI recommended the interpretation of the breakpoint should be reported as found, irrespective of whether there was ESBL production <ref type="bibr" target="#b35">[32]</ref>.</s><s>Based on the current CLSI breakpoints, 35.2% of our isolates would be resistant to piptaz.</s><s>However, in this study, we focused on the results of the treatment based on the reported antibiogram.</s><s>This goes along with the observed antimicrobial treatment showing carbapenems as mostly used agent, followed by quinolones.</s></p><p><s>This study has limitations.</s><s>It was performed retrospectively and only ESBL-positive infections were assessed.</s><s>Potential differences to ESBL-negative infections cannot be determined.</s><s>The study was conducted at a single center.</s><s>However, the data were collected from all patients within our hospital, regardless the respective department and likely represents the current course of these kind of infections in comparable hospitals.</s><s>The species identification was performed using the Vitek 2 system.</s><s>Since Vitek 2 cannot differentiate K. pneumoniae and K. variicola, it is possible that up to 10% of our analyzed K. pneumoniae isolates are K. variicola.</s><s>Future studies on carbapenem resistance should include ertapenem.</s><s>Some isolates produce weak carbapenemases and may show decreased susceptibility to this substance only.</s></p><p><s>In conclusion, ESBL-positive K. pneumoniae bacteremia compared to ESBL-positive E. coli bacteremia is often associated with complicated infection and less often with uncomplicated infection such as urinary tract infection.</s><s>In this small study group, pathogen on species level and genotypes were not associated with mortality, but with well-known factors as sepsis with organ failure.</s><s>Knowledge of colonization and source of infection should be considered for empiric anti-infective treatment, especially in patients with septic shock to reduce DAT and mortality.</s><s>Infections with ESBL-positive K. pneumoniae should be considered as more serious infections than comparable E. coli infections.</s><s>Treatment and prevention strategies should be adjusted accordingly.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting Information</head><note type="other">S1</note></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig 1 .</head><label>1</label><figDesc><div><p><s>Fig 1. Severity of sepsis in relation to mortality rate.</s><s>doi:10.1371/journal.pone.0158039.g001</s></p></div></figDesc><graphic coords="4,192.02,78.01,383.98,243.33" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>Fig 2 shows the Kaplan Meier plot for cumulative survival stratified by ESBL-E species in relation to length of stay after onset of sepsis.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Fig 2. Kaplan Meier plot for cumulative survival associated with length of stay after onset of bacteremia stratified by infecting organism ESBL-positive -E. coli vs. -K.</s><s>pneumoniae.</s><s>doi:10.1371/journal.pone.0158039.g002</s></p></div></figDesc><graphic coords="9,192.02,78.01,383.98,375.82" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Univariate analysis of clinical parameter in patients presenting with sepsis with organ failure and bacteremia.</s></p></div></figDesc><table><row><cell>Parameter</cell><cell>Bacteremia (n = 138)</cell><cell>Sepsis with organ failure (n = 81)</cell><cell>P-value</cell></row><row><cell>Age years / Age &lt; 61 years</cell><cell>67 (48.6%)</cell><cell>42 (51.9%)</cell><cell>0.676</cell></row><row><cell>Male sex</cell><cell>93 (67.4%)</cell><cell>53 (65.4%)</cell><cell>0.769</cell></row><row><cell>Charlson comorbidity index &gt; 6</cell><cell>63 (45.7%)</cell><cell>51 (63.0%)</cell><cell>0.017</cell></row><row><cell>In-hospital death</cell><cell>12 (8.7%)</cell><cell>42 (51.9%)</cell><cell>&lt;0.001</cell></row><row><cell>Polymicrobial bacteraemia</cell><cell>19 (13.8%)</cell><cell>10 (12.3%)</cell><cell>0.839</cell></row><row><cell>Hospital onset</cell><cell>74 (53.6%)</cell><cell>59 (72.8%)</cell><cell>0.006*</cell></row><row><cell>ESBL colonization before onset</cell><cell>85 (61.6%)</cell><cell>53 (65.4%)</cell><cell>0.664</cell></row><row><cell>Bacteraemia due to E. coli</cell><cell>115 (83.3%)</cell><cell>45 (55.6%)</cell><cell>&lt;0.001*</cell></row><row><cell>Bacteraemia due to K. pneumoniae</cell><cell>23 (16.7%)</cell><cell>36 (44.4%)</cell><cell></cell></row><row><cell>Origin of ESBL-E bacteraemia</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Urinary tract infection</cell><cell>55 (39.9%)</cell><cell>20 (24.7%)</cell><cell>0.027*</cell></row><row><cell>Lower respiratory tract infection</cell><cell>22 (15.9%)</cell><cell>18 (22.2%)</cell><cell>0.279</cell></row><row><cell>Intra-abdominal infection</cell><cell>9 (6.5%)</cell><cell>13 (16.0%)</cell><cell>0.035*</cell></row><row><cell>Surgical site infection</cell><cell>4 (2.9%)</cell><cell>4 (4.9%)</cell><cell>0.472</cell></row><row><cell>Primary bacteraemia</cell><cell>19 (13.8%)</cell><cell>11 (13.6%)</cell><cell>1.000</cell></row><row><cell>Other</cell><cell>6 (4.3%)</cell><cell>2 (2.5%)</cell><cell>0.756</cell></row><row><cell>Unknown Origin</cell><cell>35 (25.4%)</cell><cell>19 (23.4%)</cell><cell>0.883</cell></row><row><cell>Severity of illness and delay of anti-infective treatment</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Delayed adequate anti-infective treatment</cell><cell>70 (50.7%)</cell><cell>25 (30.9%)</cell><cell>&lt;0.001</cell></row><row><cell>ESBL Genotype</cell><cell></cell><cell></cell><cell></cell></row><row><cell>No ESBL genotype</cell><cell>4 (2.9%)</cell><cell>3 (3.7%)</cell><cell>0.711</cell></row><row><cell>CTX-M-1</cell><cell>30 (21.7%)</cell><cell>9 (11.1%)</cell><cell>0.066*</cell></row><row><cell>CTX-M-14</cell><cell>8 (5.8%)</cell><cell>6 (7.4%)</cell><cell>0.776</cell></row><row><cell>CTX-M-15</cell><cell>60 (43.5%)</cell><cell>38 (46.9%)</cell><cell>0.674</cell></row><row><cell>CTX-M-2</cell><cell>1 (0.7%)</cell><cell>-</cell><cell>1.000</cell></row><row><cell>CTX-M-2/97</cell><cell>2 (1.4%)</cell><cell>-</cell><cell>0.532</cell></row><row><cell>CTX-M-3</cell><cell>4 (2.9%)</cell><cell>2 (2.5%)</cell><cell>1.000</cell></row><row><cell>CTX-M-32</cell><cell>-</cell><cell>2 (2.5%)</cell><cell>0.136</cell></row><row><cell>CTX-M-55</cell><cell>1 (0.7%)</cell><cell>1 (1.2%)</cell><cell>1.000</cell></row><row><cell>CTX-M-61</cell><cell>1 (0.7%)</cell><cell>-</cell><cell>1.000</cell></row><row><cell>SHV-12</cell><cell>2 (1.4%)</cell><cell>-</cell><cell>0.532</cell></row><row><cell>SHV-2</cell><cell>1 (0.7%)</cell><cell>-</cell><cell>1.000</cell></row><row><cell>SHV-5</cell><cell>4 (2.9%)</cell><cell>9 (11.1%)</cell><cell>0.018*</cell></row><row><cell>SHV-7</cell><cell>-</cell><cell>1 (1.2%)</cell><cell>0.370</cell></row><row><cell>TEM-12</cell><cell>1 (0.7%)</cell><cell>-</cell><cell>1.000</cell></row><row><cell>TEM-52</cell><cell>3 (2.2%)</cell><cell>1 (1.2%)</cell><cell>1.000</cell></row><row><cell>Unknown (not available for genotype analysis)</cell><cell>16 (11.6%)</cell><cell>9 (11.1%)</cell><cell>1.000</cell></row><row><cell>Underlying conditions</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Heart disease</cell><cell>16 (11.6%)</cell><cell>23 (28.4%)</cell><cell>0.003*</cell></row><row><cell>Vascular disease</cell><cell>24 (17.4%)</cell><cell>21 (25.9%)</cell><cell>0.166*</cell></row><row><cell>Neurologic disease</cell><cell>14 (10.1%)</cell><cell>7 (8.6%)</cell><cell>0.815</cell></row><row><cell>Chronic pulmonary disease</cell><cell>17 (12.3%)</cell><cell>19 (23.5%)</cell><cell>0.038*</cell></row><row><cell>Connective tissue disease</cell><cell>3 (2.2%)</cell><cell>-</cell><cell>0.298</cell></row><row><cell>Ulcer disease</cell><cell>6 (4.3%)</cell><cell>2 (2.5%)</cell><cell>0.713</cell></row><row><cell>Liver disease</cell><cell>16 (11.6%)</cell><cell>25 (30.9%)</cell><cell>&lt;0.001*</cell></row><row><cell>Diabetes mellitus</cell><cell>34 (24.6%)</cell><cell>20 (24.7%)</cell><cell>1.000</cell></row><row><cell>Moderate to severe renal disease</cell><cell>44 (31.9%)</cell><cell>62 (76.5%)</cell><cell>&lt;0.001*</cell></row><row><cell></cell><cell></cell><cell></cell><cell>(Continued)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>(Continued)</s></p></div></figDesc><table><row><cell>Parameter</cell><cell>Bacteremia (n = 138)</cell><cell>Sepsis with organ failure (n = 81)</cell><cell>P-value</cell></row><row><cell>Cancer/immunological disease</cell><cell>63 (45.7%)</cell><cell>24 (29.6%)</cell><cell>0.022*</cell></row><row><cell>doi:10.1371/journal.pone.0158039.t001</cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>Continuous parameter are displayed as median (interquartile range), categorical parameter as number (percentage).</s><s>ESBL, extended-spectrum betalactamase.</s><s>*, parameter was included in the multivariable analysis on risk factors for severe sepsis.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Univariate analysis of survivors and non-survivors after ESBL-E sepsis</s></p></div></figDesc><table><row><cell>Univariate analysis</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>(Continued)</s></p></div></figDesc><table><row><cell>Univariate analysis</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 4 .</head><label>4</label><figDesc><div><p><s>Results of the Cox-proportional hazard regression on clinical risk factors for death afterESBL-E sepsis.</s></p></div></figDesc><table><row><cell>Parameter</cell><cell>P-value</cell><cell>HR</cell><cell>Upper-Lower CI 95</cell></row><row><cell>Bacteremia due to E.coli</cell><cell>0.060</cell><cell>1 = reference</cell><cell></cell></row><row><cell>Bacteremia due to K. pneumoniae</cell><cell></cell><cell>1.801</cell><cell>0.975-3.330</cell></row><row><cell>Urinary tract infection</cell><cell>0.007</cell><cell>0.360</cell><cell>0.172-0.754</cell></row><row><cell>Bacteremia/sepsis</cell><cell>&lt;0.001</cell><cell>1 = reference</cell><cell></cell></row><row><cell>Severe sepsis/ septic shock</cell><cell></cell><cell>4.543</cell><cell>2.134-9.673</cell></row><row><cell>Liver disease</cell><cell>0.045</cell><cell>1.801</cell><cell>1.013-3.203</cell></row><row><cell>Moderate/ severe renal disease</cell><cell>0.016</cell><cell>2.675</cell><cell>1.198-5.973</cell></row><row><cell cols="2">HR, hazard ratio. CI 95, 95% confidence interval.</cell><cell></cell><cell></cell></row><row><cell>doi:10.1371/journal.pone.0158039.t004</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head></head><label></label><figDesc><div><p><s>Table.</s><s>Univariate analysis of clinical parameter in patients with ESBL-positive bacteremia due to E. coli in comparison to K. pneumoniae.</s><s>Continuous parameter are displayed as median (interquartile range), categorical parameter as number (percentage).</s><s>ESBL, extendedspectrum beta-lactamase.</s><s>(DOCX) S2 Table.</s><s>Raw data.</s><s>(XLS)</s></p></div></figDesc><table /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | DOI:10.1371/journal.pone.0158039 July 21, 2016</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We thank Sybille Müller-Bertling and Christoph Eller for excellent technical assistance.</s><s>We furthermore thank Ivo Steinmetz for his laboratory support.</s><s>This project was executed within the scope of the RESET research consortium and was funded partly by grants from the Federal Ministry of Education and Health, Germany (01KI1013H to RL and PG).</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Contributions</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Rottier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Ammerlaan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Bonten</surname></persName>
		</author>
		<idno type="DOI">10.1093/jac/dks065</idno>
		<idno type="PMID">22396430</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of antimicrobial chemotherapy</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1311" to="1320" />
			<date type="published" when="2012-03-08">2012. 2012/03/08</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Schwaber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Carmeli</surname></persName>
		</author>
		<idno type="DOI">10.1093/jac/dkm318</idno>
		<idno type="PMID">17848376</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of antimicrobial chemotherapy</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="913" to="920" />
			<date type="published" when="2007-09-13">2007. 2007/09/13</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">Clinical characteristics of bacteraemia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type beta-lactamases. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">A</forename><surname>Qureshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Paterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Peleg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Adams-Haduch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Shutt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Pakstis</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1469-0691.2011.03658.x</idno>
		<idno type="PMID">21951551</idno>
		<idno>PMCID: PMCPmc3252485</idno>
		<imprint>
			<date type="published" when="2011-09-29">2012. 2011/09/29</date>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="887" to="893" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment</title>
		<author>
			<persName><forename type="first">M</forename><surname>Tumbarello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sanguinetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Montuori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Trecarichi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Posteraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fiori</surname></persName>
		</author>
		<idno type="DOI">10.1128/aac.01509-06</idno>
		<idno type="PMID">17387156</idno>
	</analytic>
	<monogr>
		<title level="j">Antimicrobial agents and chemotherapy</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1987" to="1994" />
			<date type="published" when="2007-03-28">2007. 2007/03/28</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title level="m" type="main">PubMed Central</title>
		<idno>PMCID: PMCPmc1891412</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ellis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Arabi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Light</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Parrillo</surname></persName>
		</author>
		<idno type="DOI">10.1378/chest.09-0087</idno>
		<idno type="PMID">19696123</idno>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1237" to="1248" />
			<date type="published" when="2009-08-22">2009. 2009/08/22</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title level="m" type="main">Comparison of Escherichia coli and Klebsiella pneumoniae liver abscesses. The American journal of the medical sciences</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Yeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Jeng</surname></persName>
		</author>
		<idno type="DOI">10.1097/MAJ.0b013e31812f59c7</idno>
		<idno type="PMID">17700198</idno>
		<imprint>
			<date type="published" when="2007-08-19">2007. 2007/08/19</date>
			<biblScope unit="volume">334</biblScope>
			<biblScope unit="page" from="97" to="105" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title level="m" type="main">Risk factors for 28-day mortality in elderly patients with extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia. Archives of gerontology and geriatrics</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Ku</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Ahn</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.archger.2013.07.002</idno>
		<idno type="PMID">23988261</idno>
		<imprint>
			<date type="published" when="2013-08-31">2014. 2013/08/31</date>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="105" to="109" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum betalactamase production and its impact on outcome</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Choi</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00277-012-1631-y</idno>
		<idno type="PMID">23161391</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of hematology</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="533" to="541" />
			<date type="published" when="2012">2013. 2012/11/20</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study</title>
		<author>
			<persName><forename type="first">G</forename><surname>Peralta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lamelo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Alvarez-Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Velasco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Delgado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Horcajada</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2334-12-245</idno>
		<idno type="PMID">23038999</idno>
		<idno>PMCID: PMCPmc3519701</idno>
	</analytic>
	<monogr>
		<title level="j">BMC infectious diseases</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">245</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort</title>
		<author>
			<persName><forename type="first">R</forename><surname>Leistner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gurntke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sakellariou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Denkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bloch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gastmeier</surname></persName>
		</author>
		<idno type="DOI">10.1007/s15010-014-0670-9</idno>
		<idno type="PMID">25100555</idno>
	</analytic>
	<monogr>
		<title level="j">Infection</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="991" to="997" />
			<date type="published" when="2014-08-08">2014. 2014/08/08</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Molecular epidemiology of extended-spectrum beta-lactamase (ESBL)-positive Klebsiella pneumoniae from bloodstream infections and risk factors for mortality</title>
		<author>
			<persName><forename type="first">S</forename><surname>Gurntke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kohler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Steinmetz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Pfeifer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Eller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gastmeier</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jiac.2014.08.012</idno>
		<idno type="PMID">25224765</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="817" to="819" />
			<date type="published" when="2014-09-17">2014. 2014/09/17</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">A new method of classifying prognostic comorbidity in longitudinal studies: development and validation</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Charlson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pompei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Ales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Mackenzie</surname></persName>
		</author>
		<idno type="PMID">3558716</idno>
	</analytic>
	<monogr>
		<title level="j">J Chronic Dis</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="373" to="383" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Thygesen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Christiansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Christensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Lash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Sorensen</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2288-11-83</idno>
		<idno type="PMID">21619668</idno>
		<idno type="PMCID">PMC3125388</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Med Res Methodol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<date type="published" when="1471">2011. 2011/05/31. 1471-2288-11-83</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Horan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Andrus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Dudeck</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ajic.2008.03.002</idno>
		<idno type="PMID">18538699</idno>
	</analytic>
	<monogr>
		<title level="j">American journal of infection control</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="309" to="332" />
			<date type="published" when="2008-06-10">2008. 2008/06/10</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Bone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Balk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Cerra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Dellinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Fein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Knaus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">The ACCP/SCCM Consensus</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Hagel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Brunkhorst</surname></persName>
		</author>
		<author>
			<persName><surname>Sepsis</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>Article in German</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title/>
		<author>
			<persName><surname>Intensivmed</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00390-010-0249-3</idno>
		<idno>doi: 10. 1007/s00390-010-0249-3</idno>
	</analytic>
	<monogr>
		<title level="j">Epub</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="57" to="73" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Performance Standards for Antimicrobial Susceptibility Testing</title>
	</analytic>
	<monogr>
		<title level="m">Twenty-second Informational Supplement M100-S22</title>
				<meeting><address><addrLine>Wayne, PA, USA</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2012">2012</date>
		</imprint>
		<respStmt>
			<orgName>CLSI</orgName>
		</respStmt>
	</monogr>
	<note>Clinical and Laboratorical Sstandards Institute (CLSI). Internet. 1-184 pp.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Emergence of carbapenemnon-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tubingen</title>
		<author>
			<persName><forename type="first">S</forename><surname>Grobner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Linke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Schutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fladerer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Madlung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Autenrieth</surname></persName>
		</author>
		<idno type="DOI">10.1099/jmm.0.005850-0</idno>
		<idno type="PMID">19502377</idno>
	</analytic>
	<monogr>
		<title level="j">Germany. Journal of medical microbiology</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="912" to="922" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>Pt 7</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Perez-Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Hanson</surname></persName>
		</author>
		<idno type="PMID">12037080</idno>
		<idno type="PMCID">PMC130804</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of clinical microbiology</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2153" to="2162" />
			<date type="published" when="2002-05-31">2002. 2002/05/ 31</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Presence of beta-lactamases in extended-spectrum-cephalosporin-resistant Salmonella enterica of 30 different serovars in Germany 2005-11</title>
		<author>
			<persName><forename type="first">C</forename><surname>Eller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Frick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Prager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Rabsch</surname></persName>
		</author>
		<idno type="DOI">10.1093/jac/dkt163</idno>
		<idno type="PMID">23674765</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of antimicrobial chemotherapy</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1978" to="1981" />
			<date type="published" when="2013-05-16">2013. 2013/05/16</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Rapid and simple determination of the Escherichia coli phylogenetic group</title>
		<author>
			<persName><forename type="first">O</forename><surname>Clermont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bonacorsi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bingen</surname></persName>
		</author>
		<idno type="PMID">11010916</idno>
		<idno>PMCID: PMCPmc92342</idno>
	</analytic>
	<monogr>
		<title level="j">Applied and environmental microbiology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="4555" to="4558" />
			<date type="published" when="2000-09-30">2000. 2000/09/30</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Comparison of in vitro activity of ertapenem with other carbapenems against extended-spectrum beta-lactamase-producing Escherichia coli and Kleibsella species isolated in a tertiary children&apos;s hospital</title>
		<author>
			<persName><forename type="first">I</forename><surname>Devrim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gulfidan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gunay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Agin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Guven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Yilmazer</surname></persName>
		</author>
		<idno type="DOI">10.1517/14656566.2011.559460</idno>
		<idno type="PMID">21323503</idno>
	</analytic>
	<monogr>
		<title level="j">Expert opinion on pharmacotherapy</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="845" to="849" />
			<date type="published" when="2011-02-18">2011. 2011/02/18</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<author>
			<persName><forename type="first">K</forename><surname>Reinhart</surname></persName>
		</author>
		<author>
			<persName><surname>S2-Leitlinie</surname></persName>
		</author>
		<title level="m">Diagnose und Therapie der Sepsis: Georg Thieme Verlag</title>
				<imprint>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Light</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Parrillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sharma</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.ccm.0000217961.75225.e9</idno>
		<idno type="PMID">16625125</idno>
	</analytic>
	<monogr>
		<title level="j">Critical care medicine</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1589" to="1596" />
			<date type="published" when="2006-04-21">2006. 2006/04/21</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title level="m" type="main">Carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase at an acute care hospital, Colorado</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Epson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Pisney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Wendt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Maccannell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Janelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kitchel</surname></persName>
		</author>
		<idno type="DOI">10.1086/675607</idno>
		<idno type="PMID">24602944</idno>
		<imprint>
			<date type="published" when="2012">2012. 2014. 2014/03/08</date>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="390" to="397" />
		</imprint>
	</monogr>
	<note>Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lubbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lippmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Busch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">X</forename><surname>Kaisers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ducomble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Eckmanns</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ajic.2013.12.001</idno>
		<idno type="PMID">24679563</idno>
	</analytic>
	<monogr>
		<title level="j">American journal of infection control</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="376" to="380" />
			<date type="published" when="2014-04-01">2014. 2014/04/01</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<title level="m" type="main">Transmission dynamics of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hilty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">Y</forename><surname>Betsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bogli-Stuber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Heiniger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stadler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kuffer</surname></persName>
		</author>
		<idno type="DOI">10.1093/cid/cis581</idno>
		<idno type="PMID">22718774</idno>
		<idno>PMCID: PMCPmc3436924</idno>
		<imprint>
			<date type="published" when="2012-06-22">2012. 2012/06/22</date>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="967" to="975" />
		</imprint>
	</monogr>
	<note>Clinical infectious diseases: an official publication of the Infectious Diseases Society of America</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Tumbarello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Trecarichi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Leone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fiori</surname></persName>
		</author>
		<idno type="DOI">10.1128/aac.00063-08</idno>
		<idno type="PMID">18591273</idno>
		<idno>PMCID: PMCPmc2533461</idno>
	</analytic>
	<monogr>
		<title level="j">Antimicrobial agents and chemotherapy</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="3244" to="3252" />
			<date type="published" when="2008-07-02">2008. 2008/07/ 02</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Widespread dissemination of CTX-M-15 genotype extended-spectrum-beta-lactamase-producing enterobacteriaceae among patients presenting to community hospitals in the southeastern United States</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nicholson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Keiger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lancaster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Joyce</surname></persName>
		</author>
		<idno type="DOI">10.1128/aac.01099-13</idno>
		<idno type="PMID">24247126</idno>
	</analytic>
	<monogr>
		<title level="j">Antimicrobial agents and chemotherapy</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="1200" to="1202" />
			<date type="published" when="2013">2014. 2013/11/20</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<monogr>
		<title level="m" type="main">PubMed Central</title>
		<idno>PMCID: PMCPmc3910860</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<title level="m" type="main">Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases</title>
		<author>
			<persName><forename type="first">A</forename><surname>Brolund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Edquist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Makitalo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Olsson-Liljequist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Soderblom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Wisell</surname></persName>
		</author>
		<idno type="DOI">10.1111/1469-0691.12413</idno>
		<idno type="PMID">24118431</idno>
		<imprint>
			<date type="published" when="2007">2007-2011. 2014. 2013/10/15</date>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="O344" to="O352" />
		</imprint>
	</monogr>
	<note>Epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in Sweden</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome</title>
		<author>
			<persName><forename type="first">M</forename><surname>Tumbarello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Spanu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sanguinetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Citton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Montuori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Leone</surname></persName>
		</author>
		<idno type="DOI">10.1128/aac.50.2.498-504.2006</idno>
		<idno type="PMID">16436702</idno>
	</analytic>
	<monogr>
		<title level="j">Antimicrobial agents and chemotherapy</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="498" to="504" />
			<date type="published" when="2006">2006. 2006/01/27. 2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title/>
		<idno>PMCID: PMCPmc1366869</idno>
	</analytic>
	<monogr>
		<title level="j">PubMed Central</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title level="m" type="main">Performance Standards for Antimicrobial Susceptibility Testing</title>
		<imprint>
			<date type="published" when="2010-06">June 2010. 2010</date>
		</imprint>
		<respStmt>
			<orgName>CLSI</orgName>
		</respStmt>
	</monogr>
	<note>Update). CLSI document M100-S20-U</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
